SHARON BIO-MEDICINE | KIMIA BIOSCIENCES | SHARON BIO-MEDICINE/ KIMIA BIOSCIENCES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 0.1 | 75.4 | 0.1% | View Chart |
P/BV | x | - | 40.0 | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
SHARON BIO-MEDICINE KIMIA BIOSCIENCES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
SHARON BIO-MEDICINE Mar-23 |
KIMIA BIOSCIENCES Mar-23 |
SHARON BIO-MEDICINE/ KIMIA BIOSCIENCES |
5-Yr Chart Click to enlarge
|
||
High | Rs | NA | 53 | 0.0% | |
Low | Rs | NA | 30 | 0.0% | |
Sales per share (Unadj.) | Rs | 338.5 | 27.2 | 1,246.1% | |
Earnings per share (Unadj.) | Rs | 33.0 | -2.0 | -1,669.1% | |
Cash flow per share (Unadj.) | Rs | 51.6 | -1.3 | -4,058.6% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | -1,024.9 | 1.2 | -88,757.4% | |
Shares outstanding (eoy) | m | 5.76 | 47.31 | 12.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 1.5 | 0.0% | |
Avg P/E ratio | x | 0 | -21.0 | -0.0% | |
P/CF ratio (eoy) | x | 0 | -32.7 | -0.0% | |
Price / Book Value ratio | x | 0 | 36.0 | -0.0% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 0 | 1,968 | 0.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 333 | 164 | 203.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 1,950 | 1,285 | 151.7% | |
Other income | Rs m | 45 | 13 | 334.8% | |
Total revenues | Rs m | 1,994 | 1,298 | 153.6% | |
Gross profit | Rs m | 254 | -61 | -412.8% | |
Depreciation | Rs m | 107 | 33 | 322.4% | |
Interest | Rs m | 1 | 42 | 1.5% | |
Profit before tax | Rs m | 190 | -124 | -153.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | -30 | -0.0% | |
Profit after tax | Rs m | 190 | -94 | -203.2% | |
Gross profit margin | % | 13.0 | -4.8 | -272.1% | |
Effective tax rate | % | 0 | 24.5 | 0.0% | |
Net profit margin | % | 9.7 | -7.3 | -133.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 1,758 | 827 | 212.5% | |
Current liabilities | Rs m | 3,391 | 764 | 443.8% | |
Net working cap to sales | % | -83.7 | 4.9 | -1,694.8% | |
Current ratio | x | 0.5 | 1.1 | 47.9% | |
Inventory Days | Days | 17 | 1 | 1,413.9% | |
Debtors Days | Days | 488 | 869 | 56.2% | |
Net fixed assets | Rs m | 1,372 | 346 | 396.6% | |
Share capital | Rs m | 12 | 47 | 24.3% | |
"Free" reserves | Rs m | -5,915 | 7 | -80,805.3% | |
Net worth | Rs m | -5,903 | 55 | -10,806.2% | |
Long term debt | Rs m | 5,580 | 308 | 1,809.6% | |
Total assets | Rs m | 3,130 | 1,173 | 266.8% | |
Interest coverage | x | 307.5 | -1.9 | -16,031.9% | |
Debt to equity ratio | x | -0.9 | 5.6 | -16.7% | |
Sales to assets ratio | x | 0.6 | 1.1 | 56.9% | |
Return on assets | % | 6.1 | -4.4 | -140.0% | |
Return on equity | % | -3.2 | -171.2 | 1.9% | |
Return on capital | % | -59.0 | -22.4 | 262.9% | |
Exports to sales | % | 73.2 | 0 | - | |
Imports to sales | % | 7.5 | 0 | - | |
Exports (fob) | Rs m | 1,428 | NA | - | |
Imports (cif) | Rs m | 145 | NA | - | |
Fx inflow | Rs m | 1,428 | 0 | - | |
Fx outflow | Rs m | 166 | 0 | - | |
Net fx | Rs m | 1,263 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 411 | -68 | -607.3% | |
From Investments | Rs m | -28 | -28 | 99.1% | |
From Financial Activity | Rs m | NA | 95 | 0.2% | |
Net Cashflow | Rs m | 384 | 0 | -142,088.9% |
Indian Promoters | % | 0.0 | 74.9 | - | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.4 | 5.3% | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 100.0 | 25.1 | 399.0% | |
Shareholders | 24,837 | 12,179 | 203.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare SHARON BIO-MEDICINE With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | SHARON BIO-MEDICINE | KIMIA BIOSCIENCES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.53% | 1.87% | 0.97% |
1-Month | -8.29% | -2.30% | 1.29% |
1-Year | -41.85% | 23.20% | 46.30% |
3-Year CAGR | -33.57% | 5.54% | 19.65% |
5-Year CAGR | -40.63% | 14.48% | 26.13% |
* Compound Annual Growth Rate
Here are more details on the SHARON BIO-MEDICINE share price and the KIMIA BIOSCIENCES share price.
Moving on to shareholding structures...
The promoters of SHARON BIO-MEDICINE hold a 0.0% stake in the company. In case of KIMIA BIOSCIENCES the stake stands at 74.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SHARON BIO-MEDICINE and the shareholding pattern of KIMIA BIOSCIENCES.
Finally, a word on dividends...
In the most recent financial year, SHARON BIO-MEDICINE paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
KIMIA BIOSCIENCES paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of SHARON BIO-MEDICINE, and the dividend history of KIMIA BIOSCIENCES.
For a sector overview, read our pharmaceuticals sector report.
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.